vs
INTELLIGENT PROTECTION MANAGEMENT CORP.（IPM）与Opus Genetics, Inc.（IRD）财务数据对比。点击上方公司名可切换其他公司
INTELLIGENT PROTECTION MANAGEMENT CORP.的季度营收约是Opus Genetics, Inc.的1.6倍（$6.1M vs $3.9M），INTELLIGENT PROTECTION MANAGEMENT CORP.同比增速更快（2091.6% vs -10.2%），过去两年INTELLIGENT PROTECTION MANAGEMENT CORP.的营收复合增速更高（54.7% vs 50.3%）
智能防护管理公司是一家总部位于英国格洛斯特郡的控股母公司，于2008年5月21日完成注册。公司为旗下四家子公司提供集团管理架构，其前身是专精于情报搜集、反间谍与反窃听检测业务的国际情报有限公司。
Opus Genetics是一家临床阶段生物技术企业，专注开发针对遗传性视网膜疾病的靶向基因疗法，致力于为患有罕见致盲性眼部疾病的患者解决未被满足的医疗需求，核心业务为面向全球罕见病市场推进可及性治疗候选药物的研发工作。
IPM vs IRD — 直观对比
营收规模更大
IPM
是对方的1.6倍
$3.9M
营收增速更快
IPM
高出2101.7%
-10.2%
两年增速更快
IPM
近两年复合增速
50.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.1M | $3.9M |
| 净利润 | — | — |
| 毛利率 | 53.1% | — |
| 营业利润率 | -13.4% | — |
| 净利率 | — | — |
| 营收同比 | 2091.6% | -10.2% |
| 净利润同比 | — | 53.0% |
| 每股收益（稀释后） | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IPMIRD
| Q4 25 | $6.1M | $3.9M | ||
| Q3 25 | $6.2M | $3.1M | ||
| Q2 25 | $5.7M | $2.9M | ||
| Q1 25 | $5.5M | $4.4M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $1.7M |
净利润IPMIRD
| Q4 25 | — | — | ||
| Q3 25 | $-1.1M | $-17.5M | ||
| Q2 25 | $-1.1M | $-7.4M | ||
| Q1 25 | $808.5K | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-7.5M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | — | $-7.1M |
毛利率IPMIRD
| Q4 25 | 53.1% | — | ||
| Q3 25 | 50.7% | — | ||
| Q2 25 | 50.1% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率IPMIRD
| Q4 25 | -13.4% | — | ||
| Q3 25 | -23.0% | -269.9% | ||
| Q2 25 | -19.7% | -309.0% | ||
| Q1 25 | -24.2% | -227.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -207.1% | ||
| Q2 24 | — | -748.9% | ||
| Q1 24 | — | -450.5% |
净利率IPMIRD
| Q4 25 | — | — | ||
| Q3 25 | -17.4% | -566.9% | ||
| Q2 25 | -18.3% | -257.5% | ||
| Q1 25 | 14.7% | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -194.6% | ||
| Q2 24 | — | -698.3% | ||
| Q1 24 | — | -415.3% |
每股收益（稀释后）IPMIRD
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.08 | $-0.25 | ||
| Q2 25 | $-0.08 | $-0.12 | ||
| Q1 25 | $0.06 | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $45.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $18.2M | $15.3M |
| 总资产 | $26.0M | $50.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IPMIRD
| Q4 25 | $5.6M | $45.1M | ||
| Q3 25 | $7.3M | $30.8M | ||
| Q2 25 | $7.3M | $32.4M | ||
| Q1 25 | $9.7M | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $41.4M | ||
| Q1 24 | — | $47.2M |
股东权益IPMIRD
| Q4 25 | $18.2M | $15.3M | ||
| Q3 25 | $18.8M | $6.0M | ||
| Q2 25 | $19.9M | $17.5M | ||
| Q1 25 | $21.1M | $5.1M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | $40.6M | ||
| Q1 24 | — | $46.1M |
总资产IPMIRD
| Q4 25 | $26.0M | $50.2M | ||
| Q3 25 | $27.2M | $36.1M | ||
| Q2 25 | $29.8M | $38.7M | ||
| Q1 25 | $31.1M | $48.2M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | — | $40.4M | ||
| Q2 24 | — | $44.8M | ||
| Q1 24 | — | $51.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.6K | $-35.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IPMIRD
| Q4 25 | $87.6K | $-35.3M | ||
| Q3 25 | $133.0K | $-6.2M | ||
| Q2 25 | $-888.7K | $-10.3M | ||
| Q1 25 | $1.7M | $-9.0M | ||
| Q4 24 | — | $-25.6M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-5.7M |
资本支出强度IPMIRD
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率IPMIRD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
IRD
暂无分部数据
